Canada Boosts Oversight of New Drugs

Included are far tougher new penalties for unsafe products, including jail time and new fines of up to $5 million per day instead of the current $5,000.

Health Canada on April 21 proposed new regulations that would allow it to identify, assess, and respond more quickly and effectively to safety issues that emerge after a drug comes on the market. The new regulations are provisions of the Protecting Canadians from Unsafe Drugs Act, known as Vanessa's Law, that did not come into effect immediately when that law was enacted in 2014.

Under them, Health Canada would be able to require companies to conduct new tests or studies or to compile new information and report back to the department. Companies also will be required to "notify Health Canada of any actions requested or required by a regulator in another jurisdiction such as risk communications, label changes, recalls, or license suspensions. Failure to comply could result in companies being subject to increased fines and penalties which have already come into force" under the act, according to the agency.

The act applies to therapeutic products, including prescription and over-the-counter drugs, vaccines, gene therapies, cells, tissues and organs, and medical devices. The amendments don't apply to natural health products, which continue to be regulated under the existing Natural Health Product Regulations of the Food and Drugs Act.

The new legislation will allow the government to:

  • Require strong surveillance, including mandatory adverse drug reaction reporting by health care institutions
  • Recall unsafe therapeutic products
  • Impose tough new penalties for unsafe products, including jail time and new fines of up to $5 million per day instead of the current $5,000
  • Provide the courts with discretion to impose even stronger fines if violations were caused intentionally
  • Compel drug companies to revise labels to clearly reflect health risk information, including potential updates for health warnings for children
  • Require drug companies to do further testing on a product, including when issues are identified with certain at-risk populations such as childrenM

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • Track Key Safety Performance Indicators

    IndustrySafe’s Dashboard Module allows organizations to easily track safety KPIs and metrics. Gain increased visibility into your business’ operations and safety data.

  • Analyze Incident Data

    Collect relevant incident data, analyze trends, and generate accurate regulatory reports, including OSHA 300, 300A, and 301 logs, through IndustrySafe’s extensive incident reporting and investigation module.

  • Safety Training 101

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Industry Safe
comments powered by Disqus

OH&S Digital Edition

  • OHS Magazine Digital Edition - March 2019

    March 2019


      Not Your Grandpa's Ear Muffs 
      Far Too Many Fatal Falls
      Marijuana in the Workplace
      Ladder Safety Tips
    View This Issue